Indicators

Markets:

News

Latest News about LGVN

Recent news which mentions LGVN

...

4 5 6 7 8 9 10 11 Next >

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

May 09, 2023

Why Is Longeveron (LGVN) Stock Up 30% Today?

May 09, 2023

Longeveron Doses First Patient In Phase 2 Clinical Trial Of Lomecel-B™ In Japan For Aging-Related Frailty

April 20, 2023

Stocks That Hit 52-Week Lows On Tuesday

March 21, 2023

Earnings Scheduled For March 10, 2023

March 10, 2023

Insiders Just Bought $1 Million of This Deep Value Tech Stock

March 07, 2023

3 Penny Stocks That Could Rise 500% in 2023

January 13, 2023

Longeveron Shares Surge Following FDA Decision on Biogen Alzheimer's Drug

January 06, 2023

Elon Musk Is a Genius Market Timer. That’s Bad News for Tesla (TSLA) Stock.

December 19, 2022

Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket

December 13, 2022

7 trade ideas for next week

October 23, 2022

How to Find Stocks That Rise 10x

October 10, 2022

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market

October 05, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

September 29, 2022

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

September 28, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

September 28, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

September 28, 2022

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket

September 28, 2022

Longeveron's Return On Capital Employed Insights

September 09, 2022

PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots

August 31, 2022

Why Is Longeveron (LGVN) Stock on the Move Today?

August 31, 2022

Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate

August 31, 2022

EXCLUSIVE: Longeveron's Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of Hypoplastic Left Heart Syndrome in Infants

August 31, 2022

European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy

August 26, 2022

European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy

August 26, 2022

EXCLUSIVE: Longeveron's Heart Disease Cell Therapy Poised To Secure European Patent

August 25, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

August 24, 2022

Longeveron: Q2 Earnings Insights

August 12, 2022

Earnings Scheduled For August 12, 2022

August 12, 2022

Longeveron Earnings Preview

August 11, 2022

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.